The Robert H. Lurie Comprehensive Cancer Center of Northwestern University (Cancer Center).is dedicated to conducting innovative early phase trials and has continued to focus on accrual to investigator-initiated trials over the previous grant period. Over the last five years the number of early phase trials open to accrual has ranged from 23 to 29 protocols, and accrual to these trials has ranged from 87-143 subjects annually (Cancer Center sites only). The Clinical Research Office (CRO) provides support for these trials. The CRO clinical research coordinators/research nurses funded by the Protocol Specific Research Support are responsible for these projects and use their expertise to manage the complexities of these types of trials. Over the past grant period a number of Cancer Center initiatives were taken to enhance the intramural program including: 1) recruitment of new faculty interested in translational research and clinical trials, 2) dedicated staff in the CRO to support the protocol initiation process, allowing improved efficiencies in protocol development and regulatory submissions, 3) an increase in experienced clinical research staff capable of managing complex early phase protocols, and 4) assigning top priority in all disease groups of Cancer Center members'investigator-initiated research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA060553-18S3
Application #
8486512
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-08-01
Project End
2013-07-31
Budget Start
2012-09-06
Budget End
2013-07-31
Support Year
18
Fiscal Year
2012
Total Cost
$201,725
Indirect Cost
$85,187
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Moinpour, Carol M; Donaldson, Gary W; Davis, Kimberly M et al. (2017) The challenge of measuring intra-individual change in fatigue during cancer treatment. Qual Life Res 26:259-271
Lamar, Tyra; Vanoye, Carlos G; Calhoun, Jeffrey et al. (2017) SCN3A deficiency associated with increased seizure susceptibility. Neurobiol Dis 102:38-48
Yu, Dou; Khan, Omar F; SuvĂ , Mario L et al. (2017) Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression. Proc Natl Acad Sci U S A 114:E6147-E6156
Mohr, David C; Tomasino, Kathryn Noth; Lattie, Emily G et al. (2017) IntelliCare: An Eclectic, Skills-Based App Suite for the Treatment of Depression and Anxiety. J Med Internet Res 19:e10
Apple, Alexandra C; Ryals, Anthony J; Alpert, Kathryn I et al. (2017) Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns. Neuroimage Clin 14:685-691
Lampe, Johanna W; Huang, Ying; Neuhouser, Marian L et al. (2017) Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort. Am J Clin Nutr 105:466-475
Ichikawa, Yuichi; Connelly, Caitlin F; Appleboim, Alon et al. (2017) A synthetic biology approach to probing nucleosome symmetry. Elife 6:
Zhou, Qiyuan; Dai, Jingbo; Chen, Tianji et al. (2017) Downregulation of PKC?/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion. Cell Signal 38:49-59
Park, Jong Kook; Peng, Han; Yang, Wending et al. (2017) miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways. FASEB J 31:256-265
Raji, Idris; Yadudu, Fatima; Janeira, Emily et al. (2017) Bifunctional conjugates with potent inhibitory activity towards cyclooxygenase and histone deacetylase. Bioorg Med Chem 25:1202-1218

Showing the most recent 10 out of 1878 publications